NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|24649145|ref|NP_651096|]
View 

Neprilysin-like 13 [Drosophila melanogaster]

Protein Classification

M13 family metallopeptidase( domain architecture ID 10171382)

M13 family metallopeptidase similar to neutral endopeptidase (neprilysin), which degrades and inactivates bioactive peptides, and to endothelin-converting enzyme, which catalyzes the hydrolysis of the bond between Trp-21 and Val-22 in big endothelin to form endothelin 1

EC:  3.4.24.-
MEROPS:  M13
SCOP:  3001975

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
68-738 3.78e-102

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


:

Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 327.40  E-value: 3.78e-102
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145  68 ADPCTDFFEYACGQWGRYHKrqLRPDE-----LSTAQQLMETKISEQLQQLLTqplppqhhpngySGASMTNVRKVRAFY 142
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHP--IPADKsswgsFSELQDRNEEQLREILEEAAS------------SAADSSAEQKAKDFY 66
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 143 ESCVAVEANASERRRFLMKILKDNGGLRNVPNSNWQhnrqwvqTLGELRRNYGLDILLGLEIDLNLQTMKGNTIYFGEPK 222
Cdd:cd08662  67 KSCMDEEAIEKLGLKPLKPLLDKIGGLPSLDDLAAE-------LLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPG 139
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 223 LTIIPAEHCnaLATRGAQVRDEVYELVQQQVTEnlrdwFGMDTGEAARFAGDIIRFEFELCK-QMGEQDIQKPEEEFPPa 301
Cdd:cd08662 140 LGLPDRDYY--LDEENAEIREAYKKYIAKLLEL-----LGADEEEAEKLAEDVLAFETELAKiSLSSEELRDPEKTYNP- 211
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 302 iqaqiygarsrtgqerlrrqkggMTLTELTsEMGNHLDFKMLVEVIL-ESQYPSQVYLRSPEYVKHVVRTVKANNRITVG 380
Cdd:cd08662 212 -----------------------LTLAELQ-KLAPSIDWKAYLKALGpPADDPDKVIVSQPEYLKKLDKLLASTPLRTLK 267
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 381 GYILYVALNE----LNQPPEEA-------------PSQRARQCVQVTQRLFPQVLGEMFQRHVQRDNAKHDLDAVFNDVI 443
Cdd:cd08662 268 NYLIWRLLDSlapyLSKEFRDArffygkalsgqkePEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIK 347
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 444 KALEEQF-HVEWMDENDRRAARTRLSQYRV------SLPDYQSLDLTDLQFQKSEDYWRRLEIALKYRSHQQFEALrGND 516
Cdd:cd08662 348 EAFKERLeNLDWMDEETKKKALEKLDAMKVkigypdKWRDYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKL-GKP 426
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 517 FGQDADGLDAFEVRAALSPRQQMVLVGWGLLQAPYYNYYYPKSLKYALLGHRLASALVQAFDDEGW------NNHPQata 590
Cdd:cd08662 427 VDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRqydengNLRNW--- 503
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 591 qWNEVTMSGYRNASECQRAQYSSYLYnEPGEFRNATR-LREIIADGSGLNLAFNAYLAWLEQQDHKLRPLLaketlselN 669
Cdd:cd08662 504 -WTNEDRKEFEERAQCLVDQYSNYEV-PPGLHVNGKLtLGENIADNGGLRLAYRAYKKWLKENGPELPGLE--------G 573
                       650       660       670       680       690       700
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 24649145 670 FTNTQLFFIYFAQTRCwAKDNQDAILDSMPLMQHTPERWDVNGPLSNSAEFGREFGCALGTPMNSGDKC 738
Cdd:cd08662 574 FTPEQLFFLSFAQVWC-SKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
68-738 3.78e-102

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 327.40  E-value: 3.78e-102
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145  68 ADPCTDFFEYACGQWGRYHKrqLRPDE-----LSTAQQLMETKISEQLQQLLTqplppqhhpngySGASMTNVRKVRAFY 142
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHP--IPADKsswgsFSELQDRNEEQLREILEEAAS------------SAADSSAEQKAKDFY 66
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 143 ESCVAVEANASERRRFLMKILKDNGGLRNVPNSNWQhnrqwvqTLGELRRNYGLDILLGLEIDLNLQTMKGNTIYFGEPK 222
Cdd:cd08662  67 KSCMDEEAIEKLGLKPLKPLLDKIGGLPSLDDLAAE-------LLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPG 139
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 223 LTIIPAEHCnaLATRGAQVRDEVYELVQQQVTEnlrdwFGMDTGEAARFAGDIIRFEFELCK-QMGEQDIQKPEEEFPPa 301
Cdd:cd08662 140 LGLPDRDYY--LDEENAEIREAYKKYIAKLLEL-----LGADEEEAEKLAEDVLAFETELAKiSLSSEELRDPEKTYNP- 211
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 302 iqaqiygarsrtgqerlrrqkggMTLTELTsEMGNHLDFKMLVEVIL-ESQYPSQVYLRSPEYVKHVVRTVKANNRITVG 380
Cdd:cd08662 212 -----------------------LTLAELQ-KLAPSIDWKAYLKALGpPADDPDKVIVSQPEYLKKLDKLLASTPLRTLK 267
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 381 GYILYVALNE----LNQPPEEA-------------PSQRARQCVQVTQRLFPQVLGEMFQRHVQRDNAKHDLDAVFNDVI 443
Cdd:cd08662 268 NYLIWRLLDSlapyLSKEFRDArffygkalsgqkePEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIK 347
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 444 KALEEQF-HVEWMDENDRRAARTRLSQYRV------SLPDYQSLDLTDLQFQKSEDYWRRLEIALKYRSHQQFEALrGND 516
Cdd:cd08662 348 EAFKERLeNLDWMDEETKKKALEKLDAMKVkigypdKWRDYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKL-GKP 426
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 517 FGQDADGLDAFEVRAALSPRQQMVLVGWGLLQAPYYNYYYPKSLKYALLGHRLASALVQAFDDEGW------NNHPQata 590
Cdd:cd08662 427 VDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRqydengNLRNW--- 503
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 591 qWNEVTMSGYRNASECQRAQYSSYLYnEPGEFRNATR-LREIIADGSGLNLAFNAYLAWLEQQDHKLRPLLaketlselN 669
Cdd:cd08662 504 -WTNEDRKEFEERAQCLVDQYSNYEV-PPGLHVNGKLtLGENIADNGGLRLAYRAYKKWLKENGPELPGLE--------G 573
                       650       660       670       680       690       700
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 24649145 670 FTNTQLFFIYFAQTRCwAKDNQDAILDSMPLMQHTPERWDVNGPLSNSAEFGREFGCALGTPMNSGDKC 738
Cdd:cd08662 574 FTPEQLFFLSFAQVWC-SKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
70-472 5.60e-48

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 174.02  E-value: 5.60e-48
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145    70 PCTDFFEYACGQWGRYHKrqLRPDE-----LSTAQQLMETKISEQLQQLLTqplppqhhpngySGASMTNVRKVRAFYES 144
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHP--IPADKsswgtFDELRERNEKQLREILEEAAA------------SESDPGAVEKAKDLYKS 66
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   145 CVAVEANASERRRFLMKILKDNGGlrnvpNSNWQHNRQWVQTLGELRRnYGLDILLGLEIDLNLQTMKGNTIYFGEPKLT 224
Cdd:pfam05649  67 CMDTDAIEKLGLKPLKPLLDEIGG-----PLANKDKFDLLETLAKLRR-YGVDSLFGFGVGPDDKNSSRNILYLDQPGLG 140
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   225 IIPAEHCNalatrgaQVRDEVYELVQQQVTENLRDWFGM--DTGEAARFAGDIIRFEFELCKqmgeqdIQKPEEEfppai 302
Cdd:pfam05649 141 LPDRDYYL-------KDRDEKSAEIREAYKAYIAKLLTLlgASEEAAALAEEVLAFETKLAK------ASLSREE----- 202
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   303 qaqiygarSRTGQERLRRqkggMTLTELTsEMGNHLDFKMLVE-VILESQYPSQVYLRSPEYVKHVVRTVKANNRITVGG 381
Cdd:pfam05649 203 --------RRDPEKTYNP----MTLAELQ-KLAPGIDWKAYLNaAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKN 269
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   382 YILYVALNE----LNQPPEEA------------PSQRARQCVQVTQRLFPQVLGEMF-QRHVQRDnAKHDLDAVFNDVIK 444
Cdd:pfam05649 270 YLIWRLVRSlapyLSDEFRDAnfefygtlsgtkQRPRWKRCVSLVNGLLGEALGRLYvKKYFPEE-AKARVEELVENIKE 348
                         410       420
                  ....*....|....*....|....*....
gi 24649145   445 ALEEQF-HVEWMDENDRRAARTRLSQYRV 472
Cdd:pfam05649 349 AFRERLdELDWMDEETKKKALEKLDAMTV 377
 
Name Accession Description Interval E-value
M13 cd08662
Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of ...
68-738 3.78e-102

Peptidase family M13 includes neprilysin and endothelin-converting enzyme I; The M13 family of metallopeptidases includes neprilysin (neutral endopeptidase, NEP, enkephalinase, CD10, CALLA, EC 3.4.24.11), endothelin-converting enzyme I (ECE-1, EC 3.4.24.71), erythrocyte surface antigen KELL (ECE-3), phosphate-regulating gene on the X chromosome (PHEX), soluble secreted endopeptidase (SEP), and damage-induced neuronal endopeptidase (DINE)/X-converting enzyme (XCE). Proteins in this family fulfill a broad range of physiological roles due to the greater variation in the active site's S2' subsite allowing substrate specificity. NEP is expressed in a variety of tissues including kidney and brain, and is involved in many physiological and pathological processes, including blood pressure and inflammatory response. It degrades a wide array of substrates such as substance P, enkephalins, cholecystokinin, neurotensin and somatostatin. It is an important enzyme in the regulation of amyloid-beta (Abeta) protein that forms amyloid plaques that are associated with Alzeimers disease (AD). ECE-1 catalyzes the final rate-limiting step in the biosynthesis of endothelins via post-translational conversion of the biologically inactive big endothelins. Like NEP, it also hydrolyzes bradykinin, substance P, neurotensin, and Abeta. Endothelin-1 overproduction has been implicated in various diseases including stroke, asthma, hypertension, and cardiac and renal failure. Kell is a homolog of NEP and constitutes a major antigen on human erythrocytes; it preferentially cleaves big endothelin-3 to produce bioactive endothelin-3, but is also known to cleave substance P and neurokinin A. PHEX forms a complex interaction with fibroblast growth factor 23 (FGF23) and matrix extracellular phosphoglycoprotein, causing bone mineralization. A loss-of-function mutation in PHEX disrupts this interaction leading to hypophosphatemic rickets; X-linked hypophosphatemic (XLH) rickets is the most common form of metabolic rickets. ECEL1 is a brain metalloprotease which plays a critical role in the nervous regulation of the respiratory system, while DINE is abundantly expressed in the hypothalamus and its expression responds to nerve injury. A majority of these M13 proteases are prime therapeutic targets for selective inhibition.


Pssm-ID: 341056 [Multi-domain]  Cd Length: 642  Bit Score: 327.40  E-value: 3.78e-102
                        10        20        30        40        50        60        70        80
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145  68 ADPCTDFFEYACGQWGRYHKrqLRPDE-----LSTAQQLMETKISEQLQQLLTqplppqhhpngySGASMTNVRKVRAFY 142
Cdd:cd08662   1 VDPCDDFYQYACGNWLKNHP--IPADKsswgsFSELQDRNEEQLREILEEAAS------------SAADSSAEQKAKDFY 66
                        90       100       110       120       130       140       150       160
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 143 ESCVAVEANASERRRFLMKILKDNGGLRNVPNSNWQhnrqwvqTLGELRRNYGLDILLGLEIDLNLQTMKGNTIYFGEPK 222
Cdd:cd08662  67 KSCMDEEAIEKLGLKPLKPLLDKIGGLPSLDDLAAE-------LLLALLRRLGVSLLFGLGVSPDPKNSSRNILYLGQPG 139
                       170       180       190       200       210       220       230       240
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 223 LTIIPAEHCnaLATRGAQVRDEVYELVQQQVTEnlrdwFGMDTGEAARFAGDIIRFEFELCK-QMGEQDIQKPEEEFPPa 301
Cdd:cd08662 140 LGLPDRDYY--LDEENAEIREAYKKYIAKLLEL-----LGADEEEAEKLAEDVLAFETELAKiSLSSEELRDPEKTYNP- 211
                       250       260       270       280       290       300       310       320
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 302 iqaqiygarsrtgqerlrrqkggMTLTELTsEMGNHLDFKMLVEVIL-ESQYPSQVYLRSPEYVKHVVRTVKANNRITVG 380
Cdd:cd08662 212 -----------------------LTLAELQ-KLAPSIDWKAYLKALGpPADDPDKVIVSQPEYLKKLDKLLASTPLRTLK 267
                       330       340       350       360       370       380       390       400
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 381 GYILYVALNE----LNQPPEEA-------------PSQRARQCVQVTQRLFPQVLGEMFQRHVQRDNAKHDLDAVFNDVI 443
Cdd:cd08662 268 NYLIWRLLDSlapyLSKEFRDArffygkalsgqkePEPRWKRCVELVNGALGEALGRLYVEKYFSEEAKADVEEMVENIK 347
                       410       420       430       440       450       460       470       480
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 444 KALEEQF-HVEWMDENDRRAARTRLSQYRV------SLPDYQSLDLTDLQFQKSEDYWRRLEIALKYRSHQQFEALrGND 516
Cdd:cd08662 348 EAFKERLeNLDWMDEETKKKALEKLDAMKVkigypdKWRDYSALDIYYDDLNVSDSYFENVLRLLRFETKRQLAKL-GKP 426
                       490       500       510       520       530       540       550       560
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 517 FGQDADGLDAFEVRAALSPRQQMVLVGWGLLQAPYYNYYYPKSLKYALLGHRLASALVQAFDDEGW------NNHPQata 590
Cdd:cd08662 427 VDRTEWSMSPQTVNAYYNPSLNEIVFPAGILQPPFFDPDAPDALNYGGIGAVIGHEITHGFDDQGRqydengNLRNW--- 503
                       570       580       590       600       610       620       630       640
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145 591 qWNEVTMSGYRNASECQRAQYSSYLYnEPGEFRNATR-LREIIADGSGLNLAFNAYLAWLEQQDHKLRPLLaketlselN 669
Cdd:cd08662 504 -WTNEDRKEFEERAQCLVDQYSNYEV-PPGLHVNGKLtLGENIADNGGLRLAYRAYKKWLKENGPELPGLE--------G 573
                       650       660       670       680       690       700
                ....*....|....*....|....*....|....*....|....*....|....*....|....*....
gi 24649145 670 FTNTQLFFIYFAQTRCwAKDNQDAILDSMPLMQHTPERWDVNGPLSNSAEFGREFGCALGTPMNSGDKC 738
Cdd:cd08662 574 FTPEQLFFLSFAQVWC-SKYRPEALRQLLLTDPHSPGKFRVNGPLSNSPEFAEAFNCPPGSPMNPEKKC 641
Peptidase_M13_N pfam05649
Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of ...
70-472 5.60e-48

Peptidase family M13; M13 peptidases are well-studied proteases found in a wide range of organizms including mammals and bacteria. In mammals they participate in processes such as cardiovascular development, blood-pressure regulation, nervous control of respiration, and regulation of the function of neuropeptides in the central nervous system. In bacteria they may be used for digestion of milk.


Pssm-ID: 461703  Cd Length: 382  Bit Score: 174.02  E-value: 5.60e-48
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145    70 PCTDFFEYACGQWGRYHKrqLRPDE-----LSTAQQLMETKISEQLQQLLTqplppqhhpngySGASMTNVRKVRAFYES 144
Cdd:pfam05649   1 PCDDFYQYACGGWLKNHP--IPADKsswgtFDELRERNEKQLREILEEAAA------------SESDPGAVEKAKDLYKS 66
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   145 CVAVEANASERRRFLMKILKDNGGlrnvpNSNWQHNRQWVQTLGELRRnYGLDILLGLEIDLNLQTMKGNTIYFGEPKLT 224
Cdd:pfam05649  67 CMDTDAIEKLGLKPLKPLLDEIGG-----PLANKDKFDLLETLAKLRR-YGVDSLFGFGVGPDDKNSSRNILYLDQPGLG 140
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   225 IIPAEHCNalatrgaQVRDEVYELVQQQVTENLRDWFGM--DTGEAARFAGDIIRFEFELCKqmgeqdIQKPEEEfppai 302
Cdd:pfam05649 141 LPDRDYYL-------KDRDEKSAEIREAYKAYIAKLLTLlgASEEAAALAEEVLAFETKLAK------ASLSREE----- 202
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   303 qaqiygarSRTGQERLRRqkggMTLTELTsEMGNHLDFKMLVE-VILESQYPSQVYLRSPEYVKHVVRTVKANNRITVGG 381
Cdd:pfam05649 203 --------RRDPEKTYNP----MTLAELQ-KLAPGIDWKAYLNaAGLPDVPSDEVIVSQPEYLKALSKLLAETPLRTLKN 269
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   382 YILYVALNE----LNQPPEEA------------PSQRARQCVQVTQRLFPQVLGEMF-QRHVQRDnAKHDLDAVFNDVIK 444
Cdd:pfam05649 270 YLIWRLVRSlapyLSDEFRDAnfefygtlsgtkQRPRWKRCVSLVNGLLGEALGRLYvKKYFPEE-AKARVEELVENIKE 348
                         410       420
                  ....*....|....*....|....*....
gi 24649145   445 ALEEQF-HVEWMDENDRRAARTRLSQYRV 472
Cdd:pfam05649 349 AFRERLdELDWMDEETKKKALEKLDAMTV 377
Peptidase_M13 pfam01431
Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which ...
545-738 1.90e-23

Peptidase family M13; Mammalian enzymes are typically type-II membrane anchored enzymes which are known, or believed to activate or inactivate oligopeptide (pro)-hormones such as opioid peptides. The family also contains a bacterial member believed to be involved with milk protein cleavage.


Pssm-ID: 279739 [Multi-domain]  Cd Length: 205  Bit Score: 98.64  E-value: 1.90e-23
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   545 GLLQAPYYNYYYPKSLKYALLGHRLASALVQAFDDEG--WNNHPQATAQWNEVTMSGYRNASECQRAQYSSY-LYNEPGE 621
Cdd:pfam01431  16 AILQPPFFDPNYPRAVNYGGIGNVIAHEITHGFDDQGaqFDKDGNLRSWWTDEDAEEFKDRAQCLIEQYSEYtPPDGTKC 95
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 24649145   622 FRNATRLREIIADGSGLNLAFNAYlawlEQQDHklrpllAKET-LSEL-NFTNTQLFFIYFAQTRCwAKDNQDAILDSMP 699
Cdd:pfam01431  96 ANGTLTLGENIADLGGLTIALRAY----KKLLS------ANETvLPGFeNLTPDQLFFRGAAQIWC-MKQSPAEVLRQLL 164
                         170       180       190
                  ....*....|....*....|....*....|....*....
gi 24649145   700 LMQHTPERWDVNGPLSNSAEFGREFGCALGTPMNSGDKC 738
Cdd:pfam01431 165 VDPHSPPEFRVNGVMSNMPAFYEAFNCPEGDKMNPEPRC 203
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH